Glenmede Investment Management’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
RP
Glenmede Investment Management's ACLS Position: Q3 2025 in Review
Glenmede Investment Management sold out of Axcelis (ACLS) in Q3 2025, closing a stake of 947 shares — an estimated $66K sold.
Glenmede Investment Management first reported a position in ACLS in Q2 2025 and held it in 1 quarter. The position peaked at $66K in Q2 2025. 360 funds tracked by Wall St. Rank hold ACLS as of Q3 2025.
- Glenmede Investment Management reported no remaining Axcelis position as of Q3 2025 after selling out during the quarter.
- Glenmede Investment Management sold 947 Axcelis shares in Q3 2025, an estimated $66K.
- Glenmede Investment Management first reported a position in Axcelis in Q2 2025 and held it in 1 quarter.
- Glenmede Investment Management's Axcelis position peaked at $66K in Q2 2025.
- 360 funds tracked by Wall St. Rank held Axcelis as of Q3 2025.
Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.